NCT00004260View on ClinicalTrials.gov

Interleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkin's Lymphoma

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 1999

Primary Completion Date

June 30, 2003

Study Completion Date

June 30, 2003

Conditions
Lymphoma
Interventions
BIOLOGICAL

recombinant interleukin-12

BIOLOGICAL

rituximab

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER